animated goddess mdbs banner animated goddess


MoonDragon's Pregnancy Information
MEDICAL MANAGEMENT OF GESTATIONAL DIABETES
by MedStudents.com


For "Informational Use Only".
For more detailed information, contact your health care provider
about options that may be available for your specific situation.




DEFINITION OF GESTATIONAL DIABETES

Gestational diabetes (GDM) is defined as glucose intolerance of variable degree with onset or first recognition during the present pregnancy. It can be screened by drawing a 1-hour glucose level following a 50-g glucose load, but is definitively diagnosed only by an abnormal 3-hour OGTT following a 100-g glucose load.




IMPORTANCE

The growth and maturation of the fetus are closely associated with the delivery of maternal nutrients, particularly glucose. This is most crucial in the third trimester and is directly related to the duration and degree of maternal glucose elevation. Thus, the negative impact is as highly diverse as the variety of carbohydrate intolerance that women bring to pregnancy.

For the mother with GDM there is a higher risk of hypertension, preeclampsia, urinary tract infections, cesarean section, and future diabetes. Many of the problems associated with overt diabetic pregnancies can be seen in infants of gestational diabetic pregnancies, such as macrosomia, neural tube defects, neonatal hypoglycemia, hypocalcemia, hypomagnsemia, hyperbilirubinemia, birth trauma, prematurity syndromes, and subsequent childhood and adolescent obesity.





PREVALENCE

The prevalence of GDM varies worldwide and among different racial and ethnic groups within a country. The variability is partly because of the different criteria and screening regimens (i.e., not all pregnant women are screened). Studies using a 100-g 3-hour OGTT and either the criteria of the National Diabetes Data Group (NDDG) or of Carpenter and Coustan have found prevalence rates of 1.4 to 12.3 percent in the United States, respectively.




PATHOPHYSIOLOGY

Gestational diabetes is pathophysiologically similar to type II diabetes. Approximately 90 percent of the persons identified have a deficiency of insulin receptors (prior to pregnancy) or a marked increase in weight that has been placed on the abdominal region. The other 10 percent have deficient insulin production and will proceed to develop mature-onset insulin-dependent diabetes.

HPL blocks insulin receptors and increases in direct linear relation to the length of pregnancy. Insulin release is enhanced in an attempt to maintain glucose homeostasis. The patient experiences increased hunger due to the excess insulin release as a result of elevated glucose levels. This insulin release further decreases insulin receptors due to elevated hormonal levels.





DIAGNOSTIC CRITERIA & SCREENING PROCEDURES

The traditional method of screening for GDM is to assess risk factors: age, pre-pregnancy weight, family history of diabetes in a first-degree relative, previous large baby, and previous perinatal loss. Unfortunately, screening based solely on risk factors will only identify approximately 50 percent of women with GDM.

Glucosuria is a common finding in pregnancy due to increased glomerular filtration and is therefore unreliable as a diagnostic finding.

The ADA (American Diabetes Association) recommend that all pregnant women, who have not been identified with glucose intolerance earlier in pregnancy, be screened with a 50-g 1-hour GCT between 24 and 28 weeks of pregnancy. Such test can be performed at anytime of the day and with disregard to previous meal ingestion.

A value equal to or above 140 mg/dL should be used as the threshold level and indicates the need for a 100-g 3-hour OGTT. For the OGTT, the patient is fasting and receives 100-g of glucose after a fasting glucose level is obtained. A blood sample is taken every hour for 3 hours. The patient is advised to sit quietly during the test to minimize the impact of exercise on glucose levels.

The glucose values used to detect gestational diabetes were first determined by O'Sullivan (1964) in a retrospective study designed to detect risk of developing type II diabetes in the future. The values were set using venous whole blood and required 2 values reaching or exceeding the value to be positive. Subsequent information has led to alteration in O'Sullivan's criteria. For example: when methods for blood glucose determination changed from the use of whole blood to venous plasma samples, the criteria for GDM were also changed once whole blood glucose values are lower than plasma levels due to glucose uptake by hemoglobin (NDDG, 1979).

Since the adoption of the NDDG criteria, more specific glucose oxidase or hexokinase tests for glucose determination have replaced older methods, and new threshold values have been calculated by Carpenter and Coustan. Sacks and co-workers also have shown that correction of the O'Sullivan's cutoffs may be necessary and suggested new cutoff values in 1989.


ORAL GLUCOSE TOLERANCE TEST (100 g)
Values For The Diagnosis of Gestational Diabetes (mg/dL)

 
O'Sullivan
NDDG (1979)
Carpenter & Coustan (1982)
Sacks et al (1989)
Fasting
90
105
95
96
1 hour
165
190
180
172
2 hour
145
165
155
152
3 hour
125
145
140
131


If one abnormal value is seen during the 100-g 3-hour OGTT it is recommended that the test be repeated approximately 1 month later. There is growing evidence that one abnormal value is sufficient to make an impact on the health of the fetus and is now the criterion used by most clinicians to initiate treatment. In a study of 106 women with one abnormal value on the OGTT, 34 percent were diagnosed with GDM when the test was repeated one month later, emphasizing the importance of repeat testing when only one abnormal value is found.

OBS (Obstetrics/Obstetricians): If GDM and fetal macrosomia begin to develop in the first trimester, then a diagnostic test to identify women at risk for GDM and to predict infants at risk for macrosomia should be accurate in the first trimester.





MEDICAL MANAGEMENT

The reason for lowering the glucose level to a normoglycemic one is to prevent diabetic complications. The goal of medical management of women with GDM, therefore, is to prevent perinatal morbidity and mortality by normalizing the level of glycemia and other metabolites (i.e., lipids and amino acids) to the levels of non-diabetic pregnant individuals.

DIETARY THERAPY

Nutritional counseling is the mainstay of therapy for the gestational diabetic woman. The optimal dietary prescription would be one that provides the calories and nutrients necessary for maternal and fetal health, results in normoglycemia, prevents ketosis, and results in appropriate weight gain.

One of the difficulties with dietary prescription for women with GDM is the difference between lean and obese women. Obese women with GDM may benefit from a low calorie diet and weight reduction to reverse the metabolic disturbances, but proper nutrition is needed to assure fetal growth and development.

Jovanovic and Peterson found the following diet to result in euglycemia:
  • 30 kcal/kg/24h present pregnant weight for normal-weight women
  • 24 kcal/kg/24h for overweight women (120 to 150 percent ideal body weight)
  • 12 to 15 kcal/kg/24h for morbidly obese women (>150 percent ideal body weight)
  • 40 kcal/kg/24h for underweight women (<80 percent ideal body weight).

They recommend that the diet be composed of 40 to 50 percent carbohydrates, 20 to 25 percent proteins, and 30 to 40 percent fats (polyunsaturated).

The patient checks her glucose 4 times daily (eg., fasting,and 1-hour postprandial breakfast, lunch, dinner). The desired values are a fasting of <90 mg/dL and a 1-hour <130 mg/dL. The average glucose levels should be ~90. After she has obtained a good understanding of her diet and the glucose values are in the desired range, she can decrease the frequency of testing to 3 days per week chosen randomly.

INSULIN THERAPY

If diet is not successful in maintaining relative euglycemia, then insulin therapy is recommended. To identify the women who will require insulin, circulating glucose levels should be monitored at frequent intervals. The ADA and ACOG (American College of Obstetricians and Gynecologists) recommend glucose measurements be taken both fasting and after meals at 1 to 2-week intervals. Insulin therapy should be initiated if the fasting glucose levels exceed 105 mg/dL and/or if the 2-hour postprandial levels exceed 120 mg/dL on two or more occasions within a 2-week interval.

Several centers, however, use the 1-hour time point because it reflects the peak glycemic response to a meal. Two studies have found that the 1-hour postprandial glucose level was a better predictor of infant birth weight than the fasting level. For this reason, when the fasting blood glucose level is 90 mg/dL or more, or the 1-hour postprandial glucose is 120 mg/dL or more on two or more glucose measurements within 1 or 2 weeks, then insulin therapy is initiated. Several regimens are possible for insulin therapy. Jovanovic and Peterson suggest the regimen seen in the tables below.



INITIAL CALCULATION OF INSULIN

 
7:30 am
4:30 pm
10:00 pm

Type
  • NPH
  • Regular
    Total

  • 8/18 I
    4/18 I
    2/3 I


    3/18 I
    1/6 I
    3/18 I


    1/6 I


    I= Insulin Dosage*
    I= 0,7U/Kg, Total 24h requirement for wk 6-18
    I= 0,8U/Kg, Total 24h requirement for wk 6-18
    I= 0,9U/Kg, Total 24h requirement for wk 6-18
    I= 1,0U/Kg, Total 24h requirement for wk 6-18





    * SLIDING SCALE FOR IRREGULAR INSULIN DOSAGE:

    7:00 am Blood Glucose
    4:30 pm Blood Glucose

    < 60 = 3/18 I
    60 to 100 = 4/18 I
    100-140 = 5/18 I
    > 140 = 6/18 I

    < 60 = 2/18I
    60 to 100 = 3/18 I
    100-140 = 4/18 I
    > 140 = 5/18 I


    Adapted from Jovanovic L, Peterson CM: Optimal insulin delivery for
    pregnant diabetic patient. Diabetes care 5 (suppl 1) : 24, 1982.


    INSULIN TITRATION

    Time Insulin
    Is
    Administered
    Insulin Type Time of Blood
    Glucose Sample
    To Monitor
    Peak Action
    Titration Procedure

    10:00 pm


    NPH


    7:00 am

      If fasting glucose is > 100 mg/dL add 2 U to 10 pm NPH
      If fasting glucose is < 60 mg/dL, decrease 10 pm NPH by 2 U

    7:30 am


    Regular


    10:00 am

      If fasting postprandial glucose is > 140 mg/dL,
      Add 2U of regular insulin to 7:30 am dose the following day

    7:30 am


    NPH


    4:00 pm

      If 4:00 pm glucose is 100 mg/dL, add 2U to 7:30 am NPH dose
      If 4:00 pm glucose is < 60 mg/dL decrease 7:30 am NPH by 2U

    4:30 pm


    Regular


    6:00 pm

      If 6:00 glucose is > 140 mg/dL, add 2U to regular insulin


    From Jovanovic L, Peterson CM: Optimal insulin delivery for pregnant diabetic patient. Diabetes care 5 (suppl 1) : 24, 1982.



    EXERCISE THERAPY

    Cardiovascular conditioning or aerobic exercise has both acute and long-term effects on insulin sensitivity, insulin secretion, and glucose metabolism. Because exercise is associated with a decrease in blood glucose concentration both acutely and after a training program and exercise training with weight control or reduction is associated with lower fasting and postprandial insulin concentrations and apparent increases in insulin sensitivity, regular exercise may be useful in the treatment or prevention of GDM.

    There are many other potential benefits of exercise training and increased cardio-respiratory fitness, such as improvement in cardiovascular risk factors and the prevention or reduction of cardiovascular complications in people with diabetes.

    Recognizing the importance of physical activity, the Third International Workshop-Conference on Gestational Diabetes has recommended exercise as a treatment modality for GDM in women who do not have a medical or obstetric contraindication for an exercise program.





    OBSTETRIC MANAGEMENT

    ANTEPARTUM CARE

    Surveillance for fetal well-being should begin between 28 and 32 weeks. Methods of fetal surveillance may include fetal kick counts, the non-stress test (NST), the contraction stress test (CST), and the biophysical profile. Signs of fetal compromise include the following: decreased fetal movement, a non-reactive NST, a positive CST and a poor biophysical profile.

    The frequency and timing of fetal surveillance depend on the severity of the disease and the degree of glycemic control. Frequent (every 4 to 6 weeks) ultrasound examinations to assess fetal growth should be performed.

    In the case of abnormal fetal testing, the practitioner should assess gestational age and, if the fetus is found to be mature, should proceed to delivery. If the fetus is intermediate in maturity, amniotic fluid assessment for pulmonary maturity may assist in the decision regarding whether delivery should be effected. If the fetus is immature, further testing such as contraction stress tests or hospitalization with continuous fetal heart rate monitoring is advised.

    Preterm labor is increased in patients with diabetes and they should be treated with magnesium sulfate as the initial tocolytic agent because the beta mimetics markedly influence glucose control. Corticosteroids increase maternal glucose levels, and this therapy may consist of continuous insulin infusion in certain cases.

    INTRAPARTUM & POSTPARTUM MANAGEMENT

    Induction of labor is recommended at 38 weeks in patients with poor glucose control and macrosomia. Insulin-requiring diabetics should be induced at 40 weeks' gestation if spontaneous labor has not occurred.

    Induction of labor may be attempted if the fetus is not excessively large and if the cervix is capable of being induced (i.e., if the cervix is soft, appreciably effaced, and somewhat dilated).

    The possibility of shoulder dystocia in the macrosomic infant of a mother with diabetes must be considered; cesarean section may be indicated to avoid the trauma of a delivering of a large infant (>4000g). Euglycemia should be maintained during labor.





    PROGNOSIS

    Women diagnosed with gestational diabetes have an increased risk of developing diabetes mellitus in the future. If they require insulin for their pregnancy, there is a 50 percent risk of diabetes within 5 years. If dietary control has been sufficient, a 60 percent risk of developing diabetes mellitus within 10 to 15 years still persists.

    For this reason, all gestationally diabetic patients should have a 75-g 3-hr glucose tolerance to evaluate for preexisting diabetes. If the 1-hr value is high, it represents decreased insulin capacity, whereas an elevated 3-hr value reflects decreased insulin receptors. In the former, limiting simple sugars in the diet should become a lifetime goal. In the latter, weight loss with increased abdominal musculature should significantly reduce the increased risk of diabetes.





    BIBLIOGRAPHY

    1. American College of Obstetricians and Gynecologists: Management of diabetes mellitus in pregnancy. ACOG Tech Bull 92:1, 1986.
    2. American Diabetes Association: Position Statement: Gestational diabetes. Diabetes Care 16 ( suppl 2 ):5, 1993.
    3. Bevier WC,Jovanovic-Peterson L, Peterson CM: Pancreatic Disorders of Pregnancy: Diagnosis, Management and Outcome of Gestational Diabetes. Endocrinology and Metabolism Clinics of North America 24:1, 1995, pp103-138.
    4. Carpenter MW, Coustan DR: Criteria for screening tests for gestational diabetes. Am.J Obstet Gynecol 144:768, 1982.
    5. Combs CA, Gavin LA, Gunderson E, et al: Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 15:1251, 1982.
    6. Coustan DR, Nelson C, Carpenter MW, et al: Maternal age and screening for gestational diabetes: A population-based study. Obstet Gynecol 73:557,1989.
    7. Jovanovic-Peterson L: Medical Management of Pregnancy Complicated by Diabetes by Diabetes. Alexandria, VA, American Diabetes Association, 1993, pp78-80.
    8. Jovanovic-Peterson L, Peterson CM, Reed G et al: Postprandial blood glucose levels predict birth weight.: The Diabetes in Early Pregnancy Study.Am.J Obstet Gynecol 164:103,1991.
    9. Metzger BE, Organizing committee: Summary and recommendations of the Third International WorkShop-Conference on Gestational Diabetes Mellitus. Diabetes 40 (suppl 2 ):197,1991.
    10. Nanda K: Medical Complications of Pregnancy. Obstetrics and Gynecology, Beck,WW; 4th ed,1996.
    11. Neiger R , Coustan DR: The role of repeat glucose tolerance tests in the diagnosis of gestational diabetes. Am J Obstet Gynecol 165:787,1991.
    12. O'Sullivan JB, Mahan CM, Charles D, Dandrow RV: Screening criteria for high-risk gestational diabetic patients. Am J Obstet
    drow RV: Screening criteria for high-risk gestational diabetic patients. Am J Obstet Gynecol 116:895,1973.





    Information obtained from MedStudents.com: Obstetrics and Gynecology





    MoonDragon's Pregnancy Information: Gestational Diabetes Index





    MoonDragon's Pregnancy Information Index
    MoonDragon's Pregnancy Information & Survival Tips






    MoonDragon's Womens Health Index

    | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |






    Health & Wellness Index





    AROMATHERAPY: ESSENTIAL OILS DESCRIPTIONS & USES


    Allspice Leaf Oil
    Angelica Oil
    Anise Oil
    Baobab Oil
    Basil Oil
    Bay Laurel Oil
    Bay Oil
    Benzoin Oil
    Bergamot Oil
    Black Pepper Oil
    Chamomile (German) Oil
    Cajuput Oil
    Calamus Oil
    Camphor (White) Oil
    Caraway Oil
    Cardamom Oil
    Carrot Seed Oil
    Catnip Oil
    Cedarwood Oil
    Chamomile Oil
    Cinnamon Oil
    Citronella Oil
    Clary-Sage Oil
    Clove Oil
    Coriander Oil
    Cypress Oil
    Dill Oil
    Eucalyptus Oil
    Fennel Oil
    Fir Needle Oil
    Frankincense Oil
    Geranium Oil
    German Chamomile Oil
    Ginger Oil
    Grapefruit Oil
    Helichrysum Oil
    Hyssop Oil
    Iris-Root Oil
    Jasmine Oil
    Juniper Oil
    Labdanum Oil
    Lavender Oil
    Lemon-Balm Oil
    Lemongrass Oil
    Lemon Oil
    Lime Oil
    Longleaf-Pine Oil
    Mandarin Oil
    Marjoram Oil
    Mimosa Oil
    Myrrh Oil
    Myrtle Oil
    Neroli Oil
    Niaouli Oil
    Nutmeg Oil
    Orange Oil
    Oregano Oil
    Palmarosa Oil
    Patchouli Oil
    Peppermint Oil
    Peru-Balsam Oil
    Petitgrain Oil
    Pine-Long Leaf Oil
    Pine-Needle Oil
    Pine-Swiss Oil
    Rosemary Oil
    Rose Oil
    Rosewood Oil
    Sage Oil
    Sandalwood Oil
    Savory Oil
    Spearmint Oil
    Spikenard Oil
    Swiss-Pine Oil
    Tangerine Oil
    Tea-Tree Oil
    Thyme Oil
    Vanilla Oil
    Verbena Oil
    Vetiver Oil
    Violet Oil
    White-Camphor Oil
    Yarrow Oil
    Ylang-Ylang Oil
    Aromatherapy
    Healing Baths For Colds
    Aromatherapy
    Herbal Cleansers
    Using Essential Oils


    AROMATHERAPY: HERBAL & CARRIER OILS DESCRIPTIONS & USES


    Almond, Sweet Oil
    Apricot Kernel Oil
    Argan Oil
    Arnica Oil
    Avocado Oil
    Baobab Oil
    Black Cumin Oil
    Black Currant Oil
    Black Seed Oil
    Borage Seed Oil
    Calendula Oil
    Camelina Oil
    Castor Oil
    Coconut Oil
    Comfrey Oil
    Evening Primrose Oil
    Flaxseed Oil
    Grapeseed Oil
    Hazelnut Oil
    Hemp Seed Oil
    Jojoba Oil
    Kukui Nut Oil
    Macadamia Nut Oil
    Meadowfoam Seed Oil
    Mullein Oil
    Neem Oil
    Olive Oil
    Palm Oil
    Plantain Oil
    Plum Kernel Oil
    Poke Root Oil
    Pomegranate Seed Oil
    Pumpkin Seed Oil
    Rosehip Seed Oil
    Safflower Oil
    Sea Buckthorn Oil
    Sesame Seed Oil
    Shea Nut Oil
    Soybean Oil
    St. Johns Wort Oil
    Sunflower Oil
    Tamanu Oil
    Vitamin E Oil
    Wheat Germ Oil





    HELPFUL RELATED MOONDRAGON NUTRITION BASICS LINKS

  • MoonDragon's Nutrition Basics Index
  • MoonDragon's Nutrition Basics: Amino Acids Index
  • MoonDragon's Nutrition Basics: Antioxidants Index
  • MoonDragon's Nutrition Basics: Enzymes Information
  • MoonDragon's Nutrition Basics: Herbs Index
  • MoonDragon's Nutrition Basics: Homeopathics Index
  • MoonDragon's Nutrition Basics: Hydrosols Index
  • MoonDragon's Nutrition Basics: Minerals Index
  • MoonDragon's Nutrition Basics: Mineral Introduction
  • MoonDragon's Nutrition Basics: Dietary & Cosmetic Supplements Index
  • MoonDragon's Nutrition Basics: Dietary Supplements Introduction
  • MoonDragon's Nutrition Basics: Specialty Supplements
  • MoonDragon's Nutrition Basics: Vitamins Index
  • MoonDragon's Nutrition Basics: Vitamins Introduction


  • NUTRITION BASICS ARTICLES

  • MoonDragon's Nutrition Basics: 4 Basic Nutrients
  • MoonDragon's Nutrition Basics: Avoid Foods That Contain Additives & Artificial Ingredients
  • MoonDragon's Nutrition Basics: Is Aspartame A Safe Sugar Substitute?
  • MoonDragon's Nutrition Basics: Guidelines For Selecting & Preparing Foods
  • MoonDragon's Nutrition Basics: Foods That Destroy
  • MoonDragon's Nutrition Basics: Foods That Heal
  • MoonDragon's Nutrition Basics: The Micronutrients: Vitamins & Minerals
  • MoonDragon's Nutrition Basics: Avoid Overcooking Your Foods
  • MoonDragon's Nutrition Basics: Phytochemicals
  • MoonDragon's Nutrition Basics: Increase Your Consumption of Raw Produce
  • MoonDragon's Nutrition Basics: Limit Your Use of Salt
  • MoonDragon's Nutrition Basics: Use Proper Cooking Utensils
  • MoonDragon's Nutrition Basics: Choosing The Best Water & Types of Water





  • RELATED MOONDRAGON HEALTH LINKS & INFORMATION

  • MoonDragon's Nutrition Information Index
  • MoonDragon's Nutritional Therapy Index
  • MoonDragon's Nutritional Analysis Index
  • MoonDragon's Nutritional Diet Index
  • MoonDragon's Nutritional Recipe Index
  • MoonDragon's Nutrition Therapy: Preparing Produce for Juicing
  • MoonDragon's Nutrition Information: Food Additives Index
  • MoonDragon's Nutrition Information: Food Safety Links
  • MoonDragon's Aromatherapy Index
  • MoonDragon's Aromatherapy Articles
  • MoonDragon's Aromatherapy For Back Pain
  • MoonDragon's Aromatherapy For Labor & Birth
  • MoonDragon's Aromatherapy Blending Chart
  • MoonDragon's Aromatherapy Essential Oil Details
  • MoonDragon's Aromatherapy Links
  • MoonDragon's Aromatherapy For Miscarriage
  • MoonDragon's Aromatherapy For Post Partum
  • MoonDragon's Aromatherapy For Childbearing
  • MoonDragon's Aromatherapy For Problems in Pregnancy & Birthing
  • MoonDragon's Aromatherapy Chart of Essential Oils #1
  • MoonDragon's Aromatherapy Chart of Essential Oils #2
  • MoonDragon's Aromatherapy Tips
  • MoonDragon's Aromatherapy Uses
  • MoonDragon's Alternative Health Index
  • MoonDragon's Alternative Health Information Overview
  • MoonDragon's Alternative Health Therapy Index
  • MoonDragon's Alternative Health: Touch & Movement Therapies Index
  • MoonDragon's Alternative Health Therapy: Touch & Movement: Aromatherapy
  • MoonDragon's Alternative Therapy: Touch & Movement - Massage Therapy
  • MoonDragon's Alternative Health: Therapeutic Massage
  • MoonDragon's Holistic Health Links Page 1
  • MoonDragon's Holistic Health Links Page 2
  • MoonDragon's Health & Wellness: Nutrition Basics Index
  • MoonDragon's Health & Wellness: Therapy Index
  • MoonDragon's Health & Wellness: Massage Therapy
  • MoonDragon's Health & Wellness: Hydrotherapy
  • MoonDragon's Health & Wellness: Pain Control Therapy
  • MoonDragon's Health & Wellness: Relaxation Therapy
  • MoonDragon's Health & Wellness: Steam Inhalation Therapy
  • MoonDragon's Health & Wellness: Therapy - Herbal Oils Index







  • For a full list of available products from Mountain Rose Herbs, click on banner below:






    Starwest Botanicals




    HerbsPro Supplement Store


    HerbsPro




    Up to 70% Off Bath & Beauty - evitamins


    eVitamins


    HCBL 10% OFF Promotion Code








    Kalyx.com Herbs, Foods, Supplements, Bath & Body


    Chinese Herbs Direct


    Ayurvedic Herbs Direct


    Pet Herbs Direct


    TakeHerb.com


    Wild Divine - Stress relief training software and meditation.


    Aleva Health - Hosiery, Orthopedics, Wound Care, Support, Diabetic Socks


    ShareASale Merchant-Affiliate Program








    MOONDRAGON'S REALM - WEBSITE DIRECTORY


    A website map to help you find what you are looking for on MoonDragon.org's Website. Available pages have been listed under appropriate directory headings.